1-14 of 14
P. Kosmidis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Study of 5-Fluorouracil and Interferon-Gamma in Patients with Metastatic Colorectal Cancer: A Hellenic Cooperative Oncology Group Study

Subject Area:
Oncology
N. Pavlidis, C. Nicolaides, A. Athanassiadis, K. Beriatou, D. Skarlos, T. Giannakakis, P. Kosmidis, N. Karvounis, G. Fountzilas
Journal: Oncology
Oncology (1996) 53 (2): 159–162.
https://doi.org/10.1159/000227553
Published Online: 30 June 2009
View article titled, Phase II Study of 5-Fluorouracil and Interferon-Gamma in Patients with Metastatic Colorectal Cancer: A Hellenic Cooperative Oncology Group Study
Open the PDF for Phase II Study of 5-Fluorouracil and Interferon-Gamma in Patients with Metastatic Colorectal Cancer: A Hellenic Cooperative Oncology Group Study in another window
Journal Articles

Cyclophosphamide, Mitoxantrone, Fluorouracil versus Conventional CMF as Adjuvant Treatment in Node-Positive Breast Cancer Patients: A Hellenic Cooperative Oncology Group Study

Subject Area:
Oncology
G. Fountzilas, A. Polichronis, K. Katsohis, K. Gennatas, D. Toussis, D. Skarlos, P. Kosmidis, S. Vassilaros, C. Semoglou, T. Giannakakis, E. Fahantidis, G. Klouvas, N. Tsavaris, C. Konstantaras, P. Makrantonakis, C. Kolotas, N. Zamboglou, S. Tsiliakos, D. Hainoglou, N. Mylonakis, N. Pavlidis
Journal: Oncology
Oncology (1996) 53 (2): 137–146.
https://doi.org/10.1159/000227550
Published Online: 30 June 2009
View article titled, Cyclophosphamide, Mitoxantrone, Fluorouracil versus Conventional CMF as Adjuvant Treatment in Node-Positive Breast Cancer Patients: A Hellenic Cooperative Oncology Group Study
Open the PDF for Cyclophosphamide, Mitoxantrone, Fluorouracil versus Conventional CMF as Adjuvant Treatment in Node-Positive Breast Cancer Patients: A Hellenic Cooperative Oncology Group Study in another window
Journal Articles

First-Line Chemotherapy of Advanced Breast Cancer with a Combination of Mitoxantrone, Methotrexate, and Vincristine (MIMO)

Subject Area:
Oncology
G. Samonis, D. Bafaloukos, A.N. Margioris, G. Katsarma, P. Toloudis, C. Bacoyannis, N. Karvounis, V. Georgoulias, P. Kosmidis
Journal: Oncology
Oncology (1997) 54 (5): 371–375.
https://doi.org/10.1159/000227721
Published Online: 30 June 2009
View article titled, First-Line Chemotherapy of Advanced Breast Cancer with a Combination of Mitoxantrone, Methotrexate, and Vincristine (MIMO)
Open the PDF for First-Line Chemotherapy of Advanced Breast Cancer with a Combination of Mitoxantrone, Methotrexate, and Vincristine (MIMO) in another window
Journal Articles

Efficacy of Ondansetron Treatment with Different Timing Schedules: A Randomized Double–Blind Study

Subject Area:
Oncology
N. Tsavaris, N. Mylonakis, Ch. Bacoyiannis, N. Karvounis, G. Charalambidis, M. Pagou, A. Lioni, D. Daliani, P. Kosmidis
Journal: Oncology
Oncology (1995) 52 (4): 315–318.
https://doi.org/10.1159/000227481
Published Online: 30 June 2009
View article titled, Efficacy of Ondansetron Treatment with Different Timing Schedules: A Randomized Double–Blind Study
Open the PDF for Efficacy of Ondansetron Treatment with Different Timing Schedules: A Randomized Double–Blind Study in another window
Journal Articles

Continuous 24-Hour Infusion of Folinic Acid Does Not Increase the Response Rate of 5-Fluorouracil but Only the Toxicity

Subject Area:
Oncology
N. Tsavaris, I. Tzannou, N. Karvounis, P. Kosmidis
Journal: Oncology
Oncology (1992) 49 (2): 154–156.
https://doi.org/10.1159/000227030
Published Online: 26 June 2009
View article titled, Continuous 24-Hour Infusion of Folinic Acid Does Not Increase the Response Rate of 5-Fluorouracil but Only the Toxicity
Open the PDF for Continuous 24-Hour Infusion of Folinic Acid Does Not Increase the Response Rate of 5-Fluorouracil but Only the Toxicity in another window
Journal Articles

Antiemetic Efficacy of High-Dose Metoclopramide and Dexamethasone in Patients Receiving Cisplatin Chemotherapy: A Randomized Trial

Subject Area:
Oncology
N. Tsavaris, E. Tsaroucha-Noutsou, C. Bacoyannis, N. Mylonakis, P. Valilis, D. Kozatsani-Halividi, H. Tsoutsos, S. Droufakou, P. Kosmidis
Journal: Oncology
Oncology (1992) 49 (6): 479–483.
https://doi.org/10.1159/000227096
Published Online: 26 June 2009
View article titled, Antiemetic Efficacy of High-Dose Metoclopramide and Dexamethasone in Patients Receiving Cisplatin Chemotherapy: A Randomized Trial
Open the PDF for Antiemetic Efficacy of High-Dose Metoclopramide and Dexamethasone in Patients Receiving Cisplatin Chemotherapy: A Randomized Trial in another window
Journal Articles

Concomitant Administration of 4-Hydroxypyrazolopyrimidine (Allopurinol) and High-Dose Continuous Infusion 5-Fluorouracil

Subject Area:
Oncology
N. Tsavaris, P. Karagiaouris, K. Vonorta, H. Bacogianis, N. Milonakis, N. Karvounis, S. Kakoliris, E. Zepou, A. Karabelis, M. Papazahariou, M. Robotas, P. Kosmidis
Journal: Oncology
Oncology (1990) 47 (1): 70–74.
https://doi.org/10.1159/000226788
Published Online: 26 June 2009
View article titled, Concomitant Administration of 4-Hydroxypyrazolopyrimidine (Allopurinol) and High-Dose Continuous Infusion 5-Fluorouracil
Open the PDF for Concomitant Administration of 4-Hydroxypyrazolopyrimidine (Allopurinol) and High-Dose Continuous Infusion 5-Fluorouracil in another window
Journal Articles

Docetaxel in Combination with Dacarbazine in Patients with Advanced Melanoma

Subject Area:
Oncology
D. Bafaloukos, G. Aravantinos, G. Fountzilas, G. Stathopoulos, H. Gogas, G. Samonis, E. Briasoulis, N. Mylonakis, D.V. Skarlos, P. Kosmidis
Journal: Oncology
Oncology (2002) 63 (4): 333–337.
https://doi.org/10.1159/000066225
Published Online: 07 November 2002
View article titled, Docetaxel in Combination with Dacarbazine in Patients with Advanced Melanoma
Open the PDF for Docetaxel in Combination with Dacarbazine in Patients with Advanced Melanoma in another window
Journal Articles

Vinblastine and Interferon-Gamma Combination with and without 13-Cis Retinoic Acid for Patients with Advanced Renal Cell Carcinoma: Results of Two Phase II Clinical Trials

Subject Area:
Oncology
C. Bacoyiannis, M.A. Dimopoulos, H.P. Kalofonos, C. Nicolaides, G. Aravantinos, D. Bafaloukos, G. Samelis, A. Onyenadum, Ch. Kiamouris, D. Skarlos, N. Pavlidis, A. Triantafillidis, P. Kosmidis, o on behalf of the Hellenic Cooperative Oncology Group (HeCOG)
Journal: Oncology
Oncology (2002) 63 (2): 130–138.
https://doi.org/10.1159/000063806
Published Online: 16 September 2002
View article titled, Vinblastine and Interferon-Gamma Combination with and without 13-Cis Retinoic Acid for Patients with Advanced Renal Cell Carcinoma: Results of Two Phase II Clinical Trials
Open the PDF for Vinblastine and Interferon-Gamma Combination with and without 13-Cis Retinoic Acid for Patients with Advanced Renal Cell Carcinoma: Results of Two Phase II Clinical Trials in another window
Journal Articles

Platinum-Based Chemotherapy of Primary Extragonadal Germ Cell Tumours: The Hellenic Cooperative Oncology Group Experience

Subject Area:
Oncology
D. Pectasides, G. Aravantinos, A. Visvikis, Ch. Bakoyiannis, A. Halikia, Ch. Kalofonos, P. Kosmidis, D. Skarlos, G. Fountzilas
Journal: Oncology
Oncology (1999) 57 (1): 1–9.
https://doi.org/10.1159/000011993
Published Online: 02 July 1999
View article titled, Platinum-Based Chemotherapy of Primary Extragonadal Germ Cell Tumours: The Hellenic Cooperative Oncology Group Experience
Open the PDF for Platinum-Based Chemotherapy of Primary Extragonadal Germ Cell Tumours: The Hellenic Cooperative Oncology Group Experience in another window
Journal Articles

Carboplatin, Methotrexate and 5-Fluorouracil in Combination with Medroxyprogesterone Acetate (JMF-M) in the Treatment of Advanced or Recurrent Endometrial Carcinoma: A Hellenic Cooperative Oncology Group Study

Subject Area:
Oncology
D. Bafaloukos, G. Aravantinos, G. Samonis, G. Katsifis, C. Bakoyiannis, D. Skarlos, P. Kosmidis
Journal: Oncology
Oncology (1999) 56 (3): 198–201.
https://doi.org/10.1159/000011965
Published Online: 08 April 1999
View article titled, Carboplatin, Methotrexate and 5-Fluorouracil in Combination with Medroxyprogesterone Acetate (JMF-M) in the Treatment of Advanced or Recurrent Endometrial Carcinoma: A Hellenic Cooperative Oncology Group Study
Open the PDF for Carboplatin, Methotrexate and 5-Fluorouracil in Combination with Medroxyprogesterone Acetate (JMF-M) in the Treatment of Advanced or Recurrent Endometrial Carcinoma: A Hellenic Cooperative Oncology Group Study in another window
Journal Articles

A Randomized Comparative Study of Antiemetic Prophylaxis with Ondansentron in a Single 32-mg Loading Dose versus 8 mg Every 6 h in Patients Undergoing Cisplatin-Based Chemotherapy

Subject Area:
Oncology
N. Tsavaris, G. Fountzilas, N. Mylonakis, A. Athanassiadis, Ch. Kosmas, C. Karakousis, Ch. Bacoyiannis, P. Kosmidis
Journal: Oncology
Oncology (1998) 55 (6): 513–516.
https://doi.org/10.1159/000011904
Published Online: 22 October 1998
View article titled, A Randomized Comparative Study of Antiemetic Prophylaxis with Ondansentron in a Single 32-mg Loading Dose versus 8 mg Every 6 h in Patients Undergoing Cisplatin-Based Chemotherapy
Open the PDF for A Randomized Comparative Study of Antiemetic Prophylaxis with Ondansentron in a Single 32-mg Loading Dose versus 8 mg Every 6 h in Patients Undergoing Cisplatin-Based Chemotherapy in another window
Journal Articles

Diffuse Large Cell Lymphomas: Identification of Prognostic Factors and Validation of the International Non-Hodgkin’s Lymphoma Prognostic Index: A Hellenic Cooperative Oncology Group Study

Subject Area:
Oncology
C. Nicolaides, G. Fountzilas, N. Zoumbos, D. Skarlos, P. Kosmidis, D. Pectasides, A. Karabelis, T. Giannakakis, A. Symeonidis, A. Papadopoulos, F. Antoniou, N. Pavlidis
Journal: Oncology
Oncology (1998) 55 (5): 405–415.
https://doi.org/10.1159/000011886
Published Online: 28 August 1998
View article titled, Diffuse Large Cell Lymphomas: Identification of Prognostic Factors and Validation of the International Non-Hodgkin’s Lymphoma Prognostic Index: A Hellenic Cooperative Oncology Group Study
Open the PDF for Diffuse Large Cell Lymphomas: Identification of Prognostic Factors and Validation of the International Non-Hodgkin’s Lymphoma Prognostic Index: A Hellenic Cooperative Oncology Group Study in another window
Journal Articles

Subcutaneous Low Doses of Interleukin-2 and Recombinant Interferon Alpha with Carboplatin and Vinblastine in Patients with Advanced Melanoma 1

Subject Area:
Oncology
D. Bafaloukos, G. Fountzilas, D. Skarlos, N. Pavlidis, C. Bakoyiannis, N. Karvounis, P. Kosmidis
Journal: Oncology
Oncology (1998) 55 (1): 48–52.
https://doi.org/10.1159/000011834
Published Online: 12 December 1997
View article titled, Subcutaneous Low Doses of Interleukin-2 and Recombinant Interferon Alpha with Carboplatin and Vinblastine in Patients with Advanced Melanoma 1
Open the PDF for Subcutaneous Low Doses of Interleukin-2 and Recombinant Interferon Alpha with Carboplatin and Vinblastine in Patients with Advanced Melanoma 1 in another window